Quick Heal Technologies Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹65 Cr −22.3% YoYSee revenue, profit and what management said. You are viewing Q1 FY24.
QH

Quick Heal Technologies Ltd

Q1 FY24IT - Software

Quick Heal Technologies Q1 FY24: Revenue ₹51.44 Cr, Net loss ₹12.76 Cr

Q1 FY24 investor presentation: what the company reported on revenue, margins and capex.

Based on Quick Heal Technologies Ltd's Q1 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹148
Market cap₹827 Cr

The short version

Q1 FY24 total revenue: ₹51.44 crores (Consolidated); down from ₹61.08 crores in Q1 FY23 Q1-FY24 EBITDA: ₹(15.08) crores, down from ₹1.05 crores in Q1-FY23 (YoY drop).

From Quick Heal Technologies Ltd's Q1 FY24 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q1 FY24 total revenue: ₹51.44 crores (Consolidated); down from ₹61.08 crores in Q1 FY23
  • Year-on-year revenue decline: approximately 15.8%
  • Consumer revenue Q1 FY24: ₹27.4 crores; Enterprise revenue Q1 FY24: ₹26.5 crores (both gross, before sales incentives)
  • Revenue decline primarily due to temporary headwinds in the consumer business
  • Enterprise segment shows sustainable growth and outperformed market growth rates, expanding in international markets (LATAM, Africa)
  • Q1 FY24 EBITDA at -₹15.1 crores vs. ₹1.1 crores in Q1 FY23; PAT declined from ₹0.2 crores to -₹12.8 crores

2 more points from Quick Heal Technologies Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Quick Heal Technologies Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in IT - Software

Ranked on what management guided this quarter

Guidance-ranked
1Workmates Core2
Rev 1Mar 1
2Virtual Galaxy
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Quick Heal Technologies Ltd said on order book & pipeline — free account, 30 seconds.

Quick Heal Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Quick Heal Technologies Ltd Q1 FY24 results?

Q1 FY24 total revenue: ₹51.44 crores (Consolidated); down from ₹61.08 crores in Q1 FY23 Q1-FY24 EBITDA: ₹(15.08) crores, down from ₹1.05 crores in Q1-FY23 (YoY drop).

What is Quick Heal Technologies Ltd share price analysis?

Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹827 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.